Bromerguride
Alternative Names: 2-bromolisuride; ZK 95451Latest Information Update: 05 Feb 1997
At a glance
- Originator Bayer Schering Pharma
- Class Antipsychotics
- Mechanism of Action Dopamine D2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 05 Feb 1997 No-Development-Reported for Psychotic disorders in Germany (PO)